Abvitro

Provides immune sequencing technology to identify novel therapeutic targets and antibodies to cancer, autoimmune and infectious diseases.

placeBoston, Massachusetts, United States calendar_todayFounded 2012 groups17 employees language abvitro.com

Innovation

9 patent families (8 granted) — focus: Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 4,920 times.

YearFilings
20141
20151
20163
20177
20188
20198
20205
20216
20227
20232
20245
20252

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon